期刊文献+

利伐沙班预防高龄骨折患者围手术期缺血卒中的疗效观察 被引量:6

下载PDF
导出
摘要 目的:观察利伐沙班预防高龄骨折患者围手术期缺血卒中的疗效,为该类患者缺血性脑卒中二级预防探索可行的药物预防方法。方法:将86例患者分为2组,观察组31例,口服利伐沙班;对照组55例应用低分子肝素钠皮下注射,并于入院当日记录神经系统症状、阳性体征并查头部CT除外颅内出血,对于有梗死病灶者记录部位。2组患者均严格控制卒中危险因素,术后第12天复查头部CT,与原片进行比较;对比神经系统症状体征;记录出血不良事件。结果:2组均未出现新发脑梗死。观察组出血发生率为3.22%;对照组出血发生率为3.63%,两组出血发生率差异无统计学意义(P>0.05)。结论:高龄骨折患者围手术期使用利伐沙班进行缺血性脑卒中二级预防安全有效,值得进一步研究。
出处 《实用医学杂志》 CAS 北大核心 2014年第3期467-469,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献2

二级参考文献22

  • 1张建政,刘树清,胥少汀.骨科围手术期血栓栓塞病的预防、诊断及治疗[J].中华外科杂志,2006,44(8):565-567. 被引量:24
  • 2邱贵兴,杨庆铭,余楠生,翁习生,王凯,李晓林.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12):819-822. 被引量:426
  • 3吕厚山.人工关节置换术后下肢深静脉血栓形成和肺栓塞的防治[J].中华创伤骨科杂志,2007,9(3):201-204. 被引量:75
  • 4Ollendorf DA,Vera-Llonch M,Oster G.Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients.Am J Health Syst Pharm,2002,59(18):1750-1754.
  • 5Geerts WH,Pineo OF,Heir JA,et al.Prevention of venous thromboembolism:the Seventh ACCP Conference on Antithromboric and Thrombolytic Therapy.Chest,2004,126 (3 Suppl):S338-400.
  • 6Mosby's Dictionary of Medicine,Nursing & Health Professions.7th ed.St.Louis,MO:Mosby,2006:115-116,335,520,1454,1849,1949.
  • 7Piovella F,Wang CJ,Lu H,et al.Deep-vein thrombosis rates after major Orthopedic surgery in Asia:an epidemiological study based on postoperative screening with centrally adjudicated bilateral venography.J Thromb Haemost,2005,3(12):2664-2670.
  • 8Heir JA,O'Fallon WM,Petterson TM,et al.Relative impact of risk factors for deep vein thrombosis and pulmonary embolism:a population-based study.Arch Intern Med,2002,162 (11):1245-1248.
  • 9Anderson FA Jr,Spencer FA.Risk factors for venous thrombcembolism.Circulation,2003,107(23 Suppl 1):9-16.
  • 10Caprini JA.Thrombosis risk assessment as a guide to quality patient care.Dis Mon,2005,51(2/3):70-78.

共引文献539

同被引文献55

  • 1中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1806
  • 2宫丽娅,龙少康,苏秀宁,王小玲.无症状脑梗塞早期诊断的探讨[J].大连医科大学学报,2006,28(4):319-320. 被引量:5
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33015
  • 4中华医学会骨科学分会.中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2009,29(2):169-171.
  • 5Wu O, Clark P, Lowe GD, et al. Thrombophilia and venous thromboembolism after total hip or knee replacement surgery : a systematic review [ J ]. J Thromb Haemost, 2013,3 ( 4 ) : 811 - 813.
  • 6Mills RM, Berkowitz RD, Damaraju CV, et al. Initiation of ri- varoxaban following low molecular weight heparin for throm- boprophylaxis after tital joint replacement: the safe, simple transitions study [ J]. Thromb Res ,2012,130 ( 5 ) :709-715.
  • 7Gerlach R, Raabe A, Beck J, et al. Postoperative nadroparin ad- ministration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after apinal surgery[J]. Eur Spine J,2010,13 ( 1 ) :9-13.
  • 8Chens JS, Arnold SL, Schulman VS, et al. Anticoagulation risk in spine surgery [ J]. Spine ,2012,35 ( 9 ) : 117-124.
  • 9Kubitza D, Becka M, Zuehlsdorf M, et al. Body weight has limited influence on the safety, tolerability, pharmacokinetics, orpharmacodynamics of rivaroxaban in healthy subjects [ J ]. J Clin Pharmaco1,2013,47 ( 2 ) :218-226.
  • 10Kubitza D, Becka M, Mueck W, et al. Safety, tolerability, pharmacodynamics, and pharmaeokinetics of rivaroxaban ano- ral. direct factor Xa inhibitor are not affected by aspirin[ J]. J Clin Pharmacol,2012,46(9) :981-990.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部